CEFIZOX Drug Patent Profile
✉ Email this page to a colleague
When do Cefizox patents expire, and when can generic versions of Cefizox launch?
Cefizox is a drug marketed by Astellas and is included in three NDAs.
The generic ingredient in CEFIZOX is ceftizoxime sodium. There are five drug master file entries for this compound. Additional details are available on the ceftizoxime sodium profile page.
Summary for CEFIZOX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 44 |
Clinical Trials: | 1 |
Patent Applications: | 5,154 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CEFIZOX at DailyMed |
Recent Clinical Trials for CEFIZOX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Khartoum | Phase 4 |
Ministry of Health, Sudan | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for CEFIZOX
US Patents and Regulatory Information for CEFIZOX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astellas | CEFIZOX | ceftizoxime sodium | INJECTABLE;INJECTION | 063294-002 | Mar 31, 1994 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Astellas | CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER | ceftizoxime sodium | INJECTABLE;INJECTION | 050589-001 | Oct 3, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Astellas | CEFIZOX | ceftizoxime sodium | INJECTABLE;INJECTION | 050560-003 | Sep 15, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |